From Specialty Pharmacy News - On Feb. 12, CMS unveiled a multipayer initiative aimed at providing better oncology care and care coordination for Medicare fee-for-service beneficiaries but at a lower cost to the program. Developed by the CMS Innovation Center, the Oncology Care Model (OCM) will reimburse providers for episodes of care in the administration of chemotherapy. “Nearly all cancers” will be included in the initiative, which also will allow beneficiaries to have 24-hour access to providers. Read more
From Drug Benefit News - Retail generic drug prices experienced record rates of inflation in 2014, putting pressure on drugstores’ profit margins and raising costs for plan sponsors. With several market factors such as the consolidation of generic manufacturers and an FDA backlog of generic drugs awaiting approval likely to remain in play, generic drug inflation may not abate any time soon, agreed industry insiders at a recent AIS webinar. Although health plans can’t manipulate the… Read more
From Specialty Pharmacy News - The Dec. 19 FDA approval of AbbVie Inc.’s Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets) to treat people with hepatitis C genotype 1 infection sparked formulary decisions among multiple payers as they attempt to drive down costs for this condition. And as the various deals are unveiled, it appears that’s exactly what’s happening. This, in turn, means the drugs are available to a broader range of… Read more
Check out all of the benefits, sample issues & more!